Elanco Animal Health (ELAN) EPS (Weighted Average and Diluted) (2017 - 2026)

Elanco Animal Health has disclosed EPS (Weighted Average and Diluted) across 10 years of filings, most recently posting $0.11 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.11, down 15.38% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.5 (down 167.57% YoY), and the FY2025 annual result was -$0.47, down 169.12% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.11 for Q1 2026 at Elanco Animal Health, up from -$0.56 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.73 in Q3 2024 to a low of -$2.22 in Q3 2023.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.02 (2022), against an average of -$0.14.
• Across the five-year window, EPS (Weighted Average and Diluted) soared 176.92% in 2022 and sank 2700.0% in 2025, its largest moves.
• Elanco Animal Health's EPS (Weighted Average and Diluted) stood at -$0.11 in 2022, then sank by 163.64% to -$0.29 in 2023, then surged by 93.1% to -$0.02 in 2024, then tumbled by 2700.0% to -$0.56 in 2025, then surged by 119.64% to $0.11 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.11 (Q1 2026), -$0.56 (Q4 2025), and -$0.07 (Q3 2025), per Business Quant data.